Bionano Genomics Reports Q3 Revenue of $8.3 Million, Up 12%

Bionano Genomics reported third-quarter 2026 revenue of $8.3 million, up 12% year over year, and gross profit of $3.9 million at a 48% margin. Operating loss was $6.5 million, and net loss was $6.5 million. The company reiterated its 2026 revenue guidance of $31 million to $33 million.Financial Hig…